Kathryn R. Wagner | DuchenneXchange

Kathryn R. Wagner, MD, PhD

Director
Center for Genetic Muscle Disorders
Kennedy Krieger Institute
Baltimore, Maryland, United States

Kathryn R. Wagner, MD, PhD is the director of the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute and a professor of neurology and neuroscience at the Johns Hopkins School of Medicine. She treats patients with muscular dystrophies in a multidisciplinary clinic, addressing the multiple medical and social issues affecting these individuals and their families.

Dr. Wagner obtained her undergraduate degree from Yale University, graduating summa cum laude with honors in biology. She participated in the NIH-funded medical scientist training program and obtained her medical and doctoral degrees at Johns Hopkins. She completed her internship in internal medicine and residency in neurology at Johns Hopkins. She also completed her neuromuscular fellowship at Johns Hopkins.

Dr. Wagner focuses her laboratory and clinical research on developing methods to promote muscle regeneration. A major emphasis has been on modulating myostatin, a potent regulator of muscle growth. She conducts clinical trials in muscular dystrophy, including the first clinical trial of nonsense suppression in Duchenne and the first clinical trial of myostatin inhibition in adult muscular dystrophy.